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F ollowing their initial identification as pro-collagen prolyl and lysyl hydroxylases, Fe(ii)-and 2-oxoglutarate (2OG)dependent oxygenases have emerged as widespread regulators of protein biosynthesis 1, 2 . The hypoxia-inducible factor (HIF) prolyl and asparaginyl hydroxylases regulate the levels and transcriptional activity of the α β -HIFs. Prolyl hydroxylation, by the prolyl hydroxylase domain oxygenases (PHDs; also known as EGLNs), regulates HIF-α subunit levels by signaling for degradation, while asparaginyl hydroxylation (catalyzed by factor inhibiting hypoxiainducible factor, FIH) regulates HIF transcriptional activity; the sensitivity of the PHDs and FIH catalysis to cellular oxygen availability enable them to act as hypoxia sensors 3 . FIH, but not the PHDs, is a member of the Jumonji-C (JmjC) subfamily of 2OG oxygenases 4 , other members of which regulate transcription via demethylation of the three histone lysine N ε -methylation states. JmjC histone demethylase (KDM) catalysis proceeds via hydroxylation to give a hemiaminal intermediate, which fragments to give the demethylated product and formaldehyde 5 . There are about six human JmjC KDM subfamilies, which are being studied due to their roles in transcription and links to cancer and genetic disorders resulting from their mutation 6 . 2OG oxygenases are current therapeutic targets with compounds being developed for clinical applications in cancer (for example, KDM5 inhibitors) 7 and anemia (PHD inhibitors) 8 .
With the exception of FIH, there are limited reports on the ~10 human JmjC oxygenases that catalyze the formation of stable alcohol products ('JmjC hydroxylases'), which are less well studied than the JmjC KDMs. In addition to HIF-α isoforms, FIH catalyzes modification of ankyrin repeat domains 9 , and Jumonji domain-containing 6 (JMJD6) catalyzes hydroxylation of splicing regulatory proteins 10 . JmjC hydroxylases also have ancient roles in the regulation of protein biosynthesis by modifying the translational machinery 11 . The ribosomal oxygenases MYC-induced nuclear antigen (MINA53) and nucleolar protein 66 (NO66) catalyze histidinyl hydroxylation of Rpl27a and Rpl8, respectively 12 . Transfer RNA yW-synthesizing enzyme 5 (TYW5) is a tRNA hydroxylase 13 , and Jumonji domaincontaining 4 (JMJD4) catalyzes hydroxylation of eukaryotic release factor 1 (eRF1), a reaction increasing stop codon recognition efficiency 14 . In eukaryotes ranging from yeasts to humans, a 2OG oxygenase that is not a JmjC protein (human: OGFOD1; Drosophila: Sudestada1), but which is related to the HIF PHDs, catalyzes hydroxylation of a prolyl residue in close contact with messenger RNA in ribosomes 15 . Overall, these results indicate that multiple 2OG oxygenases are involved in the regulation of protein synthesis at both the transcriptional and translational levels 2, 15 .
Jumonji domain-containing 7 (JMJD7) is one of the few remaining biochemically uncharacterized human JmjC oxygenases; structure-based bioinformatics predicts that it is an Fe(ii)and 2OG-dependent oxygenase containing a JmjC catalytic domain ( Supplementary Fig. 1 ). We report biochemical, crystallographic and cellular studies revealing JMJD7 to be a structurally distinct JmjC hydroxylase that catalyzes (3S)-lysyl hydroxylation in two related members of the translation factor (TRAFAC) GTPase family. The results will enable future work to elucidate The Jumonji-C oxygenase JMJD7 catalyzes (3S)-lysyl hydroxylation of TRAFAC GTPases positioned to interact with the 2OG C5 carboxylate group; notably, JMJD7 has four such side chains. In addition to Lys 193, the hydroxyls of Tyr 127, Thr 175 and Tyr 186 form additional hydrogen bonds with the 2OG C5 carboxylate group (Fig. 1b) . The apparently tight binding of 2OG is consistent with the observed slow substrate uncoupled 2OG turnover ( Supplementary Fig. 3 ).
Comparison of the JMJD7 active site with those of other JmjC oxygenases reveals closer structural similarity with JmjC hydroxylases than KDMs. Notably, binding of the 2OG C1 carboxylate, involving hydrogen bonds with the Asn-184 and Asn-289 sidechain amides, emulates interactions made by FIH 4 (that is, with the Asn-205 FIH and Asn-294 FIH side chains; Supplementary Fig. 7a ). Importantly, JMJD7 lacks a hydrophobic region crucial in binding the N ε -methyl lysine group of the JmjC KDMs 17 . Most JmjC KDMs tend to have an extended loop at the N terminus of DSBH β I that is involved in substrate binding; this is shortened in JMJD7, as in other JmjC hydroxylases ( Supplementary Fig. 7b ) 17 . Consistent with the absence of structural domains associated with KDM activity (for example, characteristic histone-and nucleic acid-binding βI  βIII  βIV  βV   βVI   βVII   βVIII   α1   α2   α4  β1 3 10 domains; Supplementary Fig. 7c ), a panel of histone H3.1 fragments known to be JmjC KDM substrates were not modified by JMJD7 ( Supplementary Fig. 8 ). Overall, the combined biophysical analyses reveal JMJD7 to have greater structural similarity to the JmjC hydroxylases than to the JmjC KDMs.
Proteomics identifies TRAFAC GTPases as JMJD7 interactors.
To identify potential JMJD7 substrates, we used mass spectrometry (MS) to compare the proteins interacting with wild-type and (near) inactive (H178A) JMJD7, using dimethyl-N-oxalylglycine (DMOG), a cell-penetrating precursor of NOG 14 , to trap substrates. Immunoaffinity purifications from extracts of DMOG-treated cells expressing FLAG-tagged wild-type or JMJD7 H178A were analyzed. JMJD7-specific interactions ablated by the H178A mutation included two closely related GTPases, developmentally regulated GTP-binding proteins 1 and 2 (DRG1/2), and their respective binding partners, DRG family regulatory proteins 1 and 2 (DFRP1/2) ( Fig. 2a and Supplementary Fig. 9a ) 22 . Known JmjC hydroxylase substrates (for example, eRF1, splicing factors, HIFα and Rpl27a/ Rpl8), ankyrins or KDM substrates (for example, histones) were not detected. Activity-dependent interactions of JMJD7 with DRG1 and DRG2 were confirmed in different cell lines ( Supplementary  Fig. 9b-d ). Reciprocal immunoprecipitations using FLAG-tagged DRGs confirmed the interaction with endogenous JMJD7, but not the related hydroxylase JMJD4 ( Supplementary Fig. 9e ). Importantly, purification of endogenous DRG-DFRP complexes also co-precipitated endogenous JMJD7 (but not JMJD4; Fig. 2b ). To investigate whether JMJD7 and DRG1/2 co-localize, immunofluorescence staining of co-expressed JMJD7 and DRG1 or DRG2 was performed in HeLa cells ( Fig. 2c ). Consistent with the proteomic and co-immunoprecipitation data, we observed significant co-localization of JMJD7 with DRG1 and DRG2 in both nuclear and cytoplasmic compartments. Overall, the combined interaction and localization data support the assignment of DRG1 and DRG2 as JMJD7 interactors and potential substrates.
JMJD7 catalyzes DRG lysyl hydroxylation.
To investigate whether DRG-DFRP complexes are JMJD7 substrates, HA-DRG1/2 and V5-DFRP1/2 were purified from cells overproducing control or FLAG-JMJD7, hydrolyzed by trypsin and then analyzed by MS. The results identified a single lysyl hydroxylation site in a highly conserved region in both DRG1 and DRG2 (that is, at Lys 22/ Lys 21, respectively; Fig. 3a,b and Supplementary Fig. 10 ). Notably, in cells overexpressing JMJD7, we reproducibly observed increases in hydroxylated peptides corresponding to a 'missed' trypsin cleavage site in DRG1 (NK(OH)ATAHHLGLLK) and DRG2 (NK(OH) ATEYHLGLLK), suggesting that JMJD7-catalyzed hydroxylation hinders trypsin-catalyzed hydrolysis (Fig. 3b ).
We then tested the cellular assignment of JMJD7-mediated DRG1/2 lysyl hydroxylation by assaying 20-mer peptide fragments spanning the DRG1 sequence as substrates (Supplementary  Table 2 ; a 25-mer peptide, DRG1 , was also used for biochemical characterization as described later in the text). Consistent with the cell results ( Fig. 3a,b and Supplementary Fig. 9 ), the only peptide undergoing a JMJD7-dependent + 16 Da shift was DRG1 [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] (NKATAHHLGLLKARLAKLRR-NH 2 ; Fig. 3c ). Peptide hydroxylation was impaired by the absence of 2OG and Fe(ii) and inhibited by NOG 18 or the use of a JMJD7-H178A variant ( Fig. 3d ). Incubation under 18 O 2 revealed that JMJD7 catalyzes incorporation of 18 O into its product, as observed for other 2OG protein hydroxylases ( Supplementary Fig. 11 ). Alanine substitution at the hydroxylation site prevented hydroxylation and blocked the interaction between isolated JMJD7 and DRG1/2 ( Supplementary Figs. 12 and 13 ). Interestingly, the DRG-hydroxylation sites are highly conserved in almost all animals including Drosophila (Fig. 3a ). Recombinant dmJMJD7 hydroxylates human DRG1 and 2 peptides with similar efficiency as human JMJD7 ( Supplementary Fig. 14a , compare to Supplementary Fig. 15 ). Furthermore, dmJMJD7 is able to reconstitute activity-dependent interactions with endogenous DRG1 and DRG2 in human cells ( Supplementary Fig. 14b ). These analyses Supplementary Fig. 9a ). 3 × FLAG wild-type or inactive (H178A) JMJD7 was produced in doxycycline-inducible HEK293T cells before anti-FLAG immunopurification (IP) and western blotting with the indicated antibodies. Note the lack of interaction of DRG and DFRP proteins with JMJD7 H178A. The specificity of endogenous DRG antibodies was verified by siRNA knockdown ( Supplementary Fig. 9f ). Immunoprecipitation experiments validating proteomic data were repeated three times, with similar results. Uncropped western blots are provided in Supplementary Fig. 27 . b, Endogenous DRG-DFRP complexes contain endogenous JMJD7. Endogenous DFRP1 (left) or DFRP2 (right) complexes were immunopurified from HEK293T cells before western blotting with the indicated antibodies. Note that immunoprecipitation samples were diluted 1:10 before analyses of 'bait' (DFRP/DRG levels). This interaction experiment was repeated three times, with similar results. Uncropped western blots are provided in Supplementary Fig. 28 . c, Co-localization of DRG1/2 and JMJD7. HeLa cells were transfected with control (empty vector, EV), FLAG-JMJD7 and/or HA-DRG1/2 before immunostaining for HA (red) and JMJD7 (green) and labeling nuclei with DAPI. This experiment was repeated three times, with similar results.
suggest that JMJD7-catalyzed DRG hydroxylation is highly conserved in animals, possibly in a manner linked to the growth phenotype observed on dmJMJD7 knockdown in Drosophila ( Supplementary Fig. 2 ). The DRG2 peptide (DRG2 20-39 ; NKATEYHLGLLKAKLAKY RA-NH 2 ) was a less efficient substrate than the analogous DRG1 [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] substrate ( Supplementary Fig. 15a,b) . A structure of the DRG1 homologue from Saccharomyces cerevisiae (ribosome-interacting GTPase 1 (RBG1), 66% sequence identity, Protein Data Bank (PDB) ID: 4A9A) reveals that the Lys-22 side chain protrudes from a loop on a highly conserved region of a helix-turn-helix (HTH) motif ( Fig. 3a and Supplementary Fig. 15c ) 23 Supplementary Fig. 10 for MS/MS fragments detected. c, Representative MALDI mass spectra for wild-type DRG1 [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] (left) and K22A DRG1 [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] (right) in the absence (black) or presence (orange) of JMJD7. The K22A substitution nearly ablates peptide hydroxylation. This experiment was repeated three times, with similar results. d, Representative MALDI-MS assays with DRG1 in the presence/ absence of co-factors/substrates and inhibitor. Ascorbate has no effect on JMJD7 activity in the linear range (the activity of some 2OG oxygenases is promoted by ascorbate 18 ). The JMJD7-H178A variant has reduced activity. The data represent the mean ± standard deviation (n = 3 replicates with a single biological sample) after incubation for 5 min at 37 °C. This assay was repeated twice, with similar results. e, MS/MS spectra of the Lys-21-hydroxylated tryptic peptide fragment from endogenous DRG2 (see Supplementary Fig 17a- c for extended data, and Supplementary Fig. 17d -f for DRG1). Note that fragments of the hydroxylated peptide lose water (− 18 Da, probably to give a C2/C3 dehydro species, consistent with C3 hydroxylation), so most b ions appear as pairs. Similar spectra were identified in multiple samples from two independent experiments. f, Quantification of endogenous DRG2 Lys-21 hydroxylation following control or JMJD7 siRNA. This experiment was repeated twice, with similar results. position of Lys 22 in the HTH of RBG1, and by implication DRG1/2, resembles that of the lysyl hydroxylation site of a JMJD4 substrate, eRF1 14 ( Supplementary Fig. 15c,d ). The location of Lys 22 protruding from a turn between two α -helices suggests that secondary structure may be important in JMJD7-substrate recognition, as for JMJD4 14 . Increasing the DRG1 fragment length at its N-terminus to include other conserved residues in the HTH (DRG1 ; ARTQKNKATAHHLGLLKARLAKLRR-NH 2 ) results in more efficient hydroxylation ( Supplementary Fig. 15a,b ). Importantly, the N-terminally extended DRG2 15-39 fragment (ARTQKNKAT EYHLGLLKAKLAKYRA-NH 2 ) undergoes efficient hydroxylation.
To investigate how JMJD7 interacts with DRG1/2, we attempted to obtain JMJD7-DRG1/2 crystal structures, but have as yet been unsuccessful. We therefore modelled JMJD7-Fe-2OG-DRG1 complexes based on the crystal structures of JMJD7-Mn-2OG (PDB: 5NFO) and S. cerevisiae RBG1 (PDB: 4A9A). The modeling and cysteine substitution studies ( Supplementary Fig. 16 ) support the combined biochemical observations implying that long-range interactions involving conserved residues distant from those immediately surrounding the hydroxylated lysine are important in Supplementary Fig. 19 ). Amino-acid analyses were repeated two or three times, with similar results. c, Currently described forms of lysyl hydroxylation and their functions. PLODs, procollagen lysyl hydroxylases. d, JMJD7 knockdown reduces the affinity of purified DRG2 for an RNA poly-C (cytidine nucleotide) agarose column. 3 × FLAG DRG2 was purified from doxycycline-inducible control shRNA cells (CON shRNA) or two independent JMJD7 shRNA cell lines (no. 2 and no. 3) before anti-FLAG purification and incubation with poly-C agarose. Captured FLAG-DRG2 was detected by anti-FLAG western blotting (right; uncropped western blots are provided in Supplementary Fig. 39 ) and quantified in three independent experiments, with similar results (left): the data represent the mean ± s.e.m. (n = 3 biologically independent experiments) analyzed by two-sided Student's t-test (**P < 0.01; P = 0.0016 for JMJD7 shRNA2 and 0.0082 for JMJD7 shRNA3).
productive JMJD7 binding. Overall, the combined cellular and isolated protein studies define JMJD7 as a lysyl hydroxylase acting on both DRG1 and DRG2.
To investigate whether JMJD7 is necessary for hydroxylation of DRGs, we immunopurified endogenous DRG1/2 from HEK293T cells ( Supplementary Fig. 17 ); MS analyses identified substantial levels of both Lys 22 ( Supplementary Fig. 17d ) and Lys 21 ( Fig. 3e ,f) hydroxylation, respectively. Importantly, endogenous levels of DRG2 Lys-21 hydroxylation were dependent on the presence of JMJD7 expression ( Fig. 3f and Supplementary Fig. 17b ). Consistent with the overexpression analyses ( Fig. 3b and Supplementary Fig. 10 ), the ability of trypsin to cleave endogenous DRGs at the C-terminal side of Lys 22/Lys 21 was reduced following hydroxylation ( Fig. 3f ). We also observed inhibition of DRG hydrolysis by hydroxylation with Lys-N, which cleaves at the N-terminal side of lysyl residues ( Supplementary Fig. 18 ). This phenomenon has not been reported following hydroxylation of lysine at the C4 or C5 positions by protein hydroxylases 14, 24, 25 , implying that JMJD7 catalyzes a novel form of lysyl hydroxylation.
JMJD7 is a (3S)-lysyl hydroxylase. To date, characterized 2OG oxygenases catalyze hydroxylation at the C4 (for example, JMJD4 14 ) and C5 (for example, JMJD6 and the procollagen lysyl hydroxylases 10, 26 ) positions of lysyl side chains. To investigate the regio-and stereo-selectivity of JMJD7, a DRG1 peptide was hydroxylated, and then hydrolyzed and subjected to amino-acid analysis. Following derivatization, LC-MS revealed a new peak, not present in controls, with a mass corresponding to derivatized hydroxylysine (observed 503.2162 Da; calculated 503.2037 Da). Comparison using C3, C4 and C5 hydroxylysine standards 14 reveals that the product co-elutes with one of the C3 hydroxylysine enantiomeric pairs ( Fig. 4a and Supplementary Fig. 19 ); C3 hydroxylation is supported by NMR analyses of hydroxylated DRG1 and DRG2 peptides ( Supplementary  Fig. 20 ). Comparison with a diastereomeric mixture of C3 hydroxylysine isomers and synthetic (2S,3R)/(2R,3S)-hydroxylysine standard 27 identified (2S,3S)-hydroxylysine as the JMJD7-catalyzed product ( Fig. 4b and Supplementary Fig. 19c,d ). No evidence for other isomers was observed within detection limits, revealing that JMJD7 stereospecifically catalyzes (3S)-hydroxylation ( Fig. 4a -c; assuming retention of (2S)-stereochemistry).
DRG hydroxylation promotes ribonucleic acid binding. The effect of C3 lysyl hydroxylation on in vitro proteolysis suggests that this post-translational modification can regulate intramolecular interactions with functional consequences. We therefore explored potential biological roles of DRG C3 lysyl hydroxylation. Unlike HIF hydroxylases, JMJD7 did not significantly regulate substrate levels: Overexpression of wild-type or H178A JMJD7 ( Fig. 2a and Supplementary Fig. 9b-d) , treatment with DMOG ( Supplementary  Fig. 9b-d) or DRG hydroxylation site mutation ( Supplementary  Figs. 21 and 22 ) did not consistently affect the expression of DRG or DFRP proteins in cells. Furthermore, hydroxylation did not, within detection limits, change the thermal stability of full-length, isolated DRG1 (using differential scanning calorimetry; Supplementary  Fig. 23 ). Consistent with the lack of effect on cellular stability, hydroxylation site substituted DRGs did not affect their ability to co-precipitate DFRPs, which are major regulators of DRG protein turnover 22 (Supplementary Fig. 21 ). Hydroxylation also did not consistently affect GTPase activity, as determined by 1 H NMR or phosphate release assays using recombinant DRG1 in vitro ( Supplementary Fig. 24 ), or using DRG1/2 purified from cells exposed to JMJD7 overexpression, short hairpin RNA (shRNA) knockdown or DMOG treatment ( Supplementary Fig. 25 ).
As described above, the lysine residue targeted by JMJD7 is located at the apex of a highly conserved HTH motif within the N-terminal regions of DRG1/2 ( Supplementary Fig. 15c ). Although the role of this domain has not previously been reported, yeast complementation studies reveal that it is critical for DRG function 28 . JMJD7-mediated DRG hydroxylation is analogous to JMJD4-mediated eRF1 hydroxylation ( Supplementary Fig. 15c,d) , in the sense that both are lysyl hydroxylation events targeting HTH domains. eRF1 lysyl hydroxylation is thought to promote translation termination by supporting the interaction of eRF1 with the mRNA stop codon 14 , raising the possibility that DRG lysyl hydroxylation catalyzed by JMJD7 has a related function. Indeed, we observed significant binding of DRG2 to RNA affinity columns ( Supplementary  Fig. 22 ; consistent with previous reports 29 ). Furthermore, a DRG2 Lys-21 variant had reduced affinity for RNA, thus localizing RNAbinding activity to the HTH domain ( Supplementary Fig. 22 ). Importantly, shRNA-mediated JMJD7 knockdown also reduced the RNA binding affinity of purified DRG2 ( Fig. 4d and Supplementary  Fig. 22d ). These data support a role for JMJD7-mediated C3 lysyl hydroxylation in promoting the interaction of the DRG TRAFAC GTPases with RNA. Future work can focus on defining the precise nature of the JMJD7-DRG-DFRP ribonucleoprotein complexes and their biological roles.
Discussion
The combined cellular and biochemical results demonstrate that JMJD7 targets highly conserved lysine residues within two closely related TRAFAC GTPase proteins. The finding that JMJD7 catalyzes (3S)-lysyl hydroxylation expands the repertoire of 2OG oxygenase-catalyzed modifications of basic residues, which also include histidinyl hydroxylation 12, 30 , lysyl C4 hydroxylation 14 , lysyl (5S)-and (5R)-hydroxylation 24, 26 , N ε -methyl lysyl demethylation 31 , argininyl C3 hydroxylation 12 and, possibly, N-methyl argininyl demethylation 32 . The extent of 2OG oxygenase-catalyzed lysyl hydroxylation is striking. With the discovery of JMJD7-catalyzed C3 lysyl hydroxylation, a total of seven different sites of lysine side chain oxidations is now known to be catalyzed by 2OG oxygenases. Aside from the 'not (yet) observed' C3 and C4 stereoisomers, oxidation reactions at the C2 and C6 positions are unidentified exceptions; although the products of such reactions are probably unstable, they have precedence in 2OG oxygenase-catalyzed protein fragmentation (albeit not at lysine residues as yet) via C2 hydroxylation 33 .
In most cases, the detailed biochemical roles of lysyl hydroxylations are unclear, with the enablement of glycosylation by procollagen (5R)-lysyl hydroxylation 26 and improved stop codon decoding by C4 lysyl hydroxylation 14, 34, 35 being exceptions. Our experiments indicate that JMJD7-catalyzed hydroxylation does not substantially affect the intrinsic stability, protein expression or GTPase activity of DRGs. Interestingly, however, we observed that JMJD7-catalyzed C3 lysyl hydroxylation clearly impairs experimental proteolysis, at either the C-or N-terminal sides of the target lysyl residue. While inhibition of the tested proteases is probably not biologically relevant, this observation raises the possibility of a wider role for protein hydroxylation in directly modulating protease hydrolysis. This is particularly attractive for C3 lysyl hydroxylation and nucleophilic serine/threonine protease inhibition, where work with proteases and bacterial cell wall biosynthesis enzymes employing nucleophilic serine catalysis has revealed that substrate/inhibitor substitutions that perturb hydrolysis (or formation) of the acylenzyme complex can lead to inhibition 36 .
In addition to effects on protease hydrolysis, we observed JMJD7-and hydroxylation site-dependent regulation of RNA binding, analogous to the role of JMJD4 in promoting mRNA stop codon decoding by eRF1 14 . Although future work is required to address the physiological RNA targets, the presence of DRGs in ribosome fractions from diverse species including yeasts, plants and humans 28, 37, 38 could be consistent with an interaction with messenger or ribosomal RNA. Although the biochemical role of the DRGs in protein translation is unclear, it is consistent with their similarity to other OBG GTPases of the TRAFAC family, which have roles in ribosome biogenesis and translation control 23, 39 . A prokaryotic 2OG-dependent prolyl hydroxylase homologous with the animal HIF prolyl hydroxylases, elongation factor thermo unstable (EF-Tu), has also been found to catalyze hydroxylation of a loop region of a translation-associated GTPase 40 ; thus, physical and functional interactions between 2OG oxygenases, translation factors and RNA may have ancient origins.
The discovery of JMJD7-catalyzed DRG hydroxylation contributes to growing evidence on the importance of the dynamic interactions between 2OG oxygenases and their substrates/interacting partners in disease 6, 41 . Both JMJD7 and DRG1/DRG2 are linked to cell growth in diverse cell types and species 29, 37, [42] [43] [44] . JMJD7 and DRG1/2 may also have context-dependent roles in diseases including cancer and mental disorders; the DRG2 gene is located in a chromosomal region implicated in the Smith-Magenis neurobehavioral syndrome 45 , and DRG1/2 SNPs have been identified in a screen of candidate genes for autism spectrum disorders 46 . In support of this, genetic studies in high-risk autism families and people with severe intellectual disabilities have identified two substitutions in the JMJD7 gene 20, 47 . Future work can now address whether JMJD7catalyzed hydroxylation of DRG1/2 regulates protein synthesis and how this underlies the role of this novel pathway in growth control and disease.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41589-018-0071-y. 

Analysis of growth phenotypes in Drosophila melanogaster.
Drosophila maintenance, engineering and knockdowns were performed as described previously 48 . Flies used in this study were en-Gal4 from the Bloomington Drosophila Stock Center and white RNAi (as a control) and CG10133 RNAi from the VDRC Stock Center. For analysis of growth phenotypes, wings from 4-day-old females and males were removed and mounted in a solution containing 1:1 lactic acid/ethanol. Wings were imaged using an Olympus MVX10 stereomicroscope connected to an Olympus DP71 digital camera, and variations in the area of the posterior compartment were estimated by measuring the area comprised between veins L4, PCV and L5, using the ImageJ software (NIH, USA). To quantify variations of cell size, the number of wing hairs per square millimeter was counted from images taken with an Olympus BX60 microscope connected to an Olympus DP71 digital camera.
Mammalian cell culture and transfection. Human tumor and HEK293T cell lines were cultured in DMEM supplemented with 10% FBS (Sigma) and 1% penicillin-streptomycin at 37 °C in a humidified atmosphere with 5% CO 2 . Plasmids were transfected using FuGENE6 Transfection Reagent The pET28a-JMJD7 plasmid was prepared by W.G. and generated by inserting the human JMJD7 gene (encoding full-length JMJD7, residues 1-316, NCBI gene accession number: 100137047) into the pET28a vector (Novagen) for production in Escherichia coli with an N-terminal His 6 tag and a thrombin protease cleavage site (MGSSHHHHHHSSGLVPR*GSH). The following human JMJD7 constructs (residues 1-316, 1-295, , which were used to investigate oligomerization of JMJD7, were amplified from pET28a-JMJD7 using custom primers (Sigma Aldrich) and cloned into the pNIC28-Bsa4 vector using ligation-independent cloning, resulting in constructs with an N-terminal His 6 tag and a tobacco etch virus (TEV) protease cleavage site (MHHHHHHSSGVDLGTENLYFQ*SM). Genes encoding full-length DRG1 (residues 1-367, NCBI gene accession number: 4733) and DRG2 (residues 1-364; NCBI gene accession number: 1819) were amplified from U2-OS cDNA (kindly provided by L. Walport, University of Oxford) and also inserted into the pNIC28-Bsa4 vector. Site-directed mutagenesis was performed using custom primers (Invitrogen or Sigma Aldrich) and either Phusion High-Fidelity PCR Master Mix with HF Buffer (NEB) or the Stratagene QuikChange method with Q5 High-Fidelity DNA Polymerase (NEB). PCR was carried out according to the manufacturer's recommendations followed by DpnI (ThermoFisher) digestion for 60 min at 37 °C before DNA purification and bacterial transformation. All constructs were fully DNA-sequence-verified.
Immunofluorescence. HeLa cells were seeded onto glass coverslips the day before transfection with pCDNA3 FLAG-JMJD7 and/or HA-DRG1/2. After 48 h, cells were washed three times with cold PBS before fixing with 4% PFA (15 min, room temperature) and permeabilizing with TBSTritonx100 (10 min, room temperature). Immunofluorescence co-staining was achieved by incubating samples with primary antibodies at 4 ˚C overnight. Secondary antibodies (Alexa Fluor 555 anti-mouse and Alexa Fluor 488 nm anti-rabbit (ThermoFisher)) were incubated at 1:2,000 for 1 h at room temperature before DAPI (Sigma) staining. Coverslips were mounted onto slides using anti-fade mounting medium (NEB ProLong Gold) and imaged using a Zeiss LSM510.
Protein expression analyses. Cellular proteins were extracted using either JIES (20 mM Tris-HCl pH 7.4, 100 mM NaCl, 5 mM MgCl 2 , 0.5% (v/v) Igepal CA-630 and complete protease inhibitors (Roche)) or radioimmunoprecipitation assay buffer. Protein extracts were quantified and equalized using Pierce 660 nm Protein Assay Reagent. Western blotting antibodies were as described above. Signals were developed using SuperSignal West Pico, Dura or Femto chemiluminescent substrates (Thermo Fisher Scientific).
JMJD7 proteomic screen. Inducible FLAG-JMJD7 stable cell lines (wild type and H178A variant) were treated with doxycycline (Sigma) for 38 h before the addition of 1 mM DMOG (Sigma, D3695) for 16 h, to trap substrates. Cells were lysed in JIES in the presence of 1 mM NOG (Cambridge Bioscience, 13944), before immunoprecipitation with anti-FLAG M2 Magnetic Beads (Sigma, M8823), overnight at 4 °C with rotation. Samples were then washed six times in JIES before elution with 100 μ g ml −1 3 × FLAG peptide (Sigma, F4799). Eluents were desalted by methanol/chloroform extraction before in-solution trypsin digestion using standard methods 49 . Purified tryptic peptides were analyzed by mass spectrometry (as detailed below) in technical triplicates to allow for label-free quantification.
JMJD7-DRG interaction assays. Doxycycline-inducible FLAG-JMJD7 stable cell lines were treated with doxycycline as above before the addition, or not, of 1 mM DMOG for 10-16 h. Cells were lysed in JIES in the presence or absence of 1 mM NOG before immunoprecipitation with anti-FLAG beads, overnight at 4 °C with rotation. Samples were then washed six times in JIES before elution with 100 μ g ml −1 3 × FLAG peptide. The interaction of transfected FLAG-DRG1/2 with endogenous JMJD7 was explored using an identical approach. Endogenous DRG-DFRP-JMJD7 complexes were analyzed by immunoprecipitation from large-scale DMOG-treated HEK293T cell extracts using DFRP antibodies bound to protein A agarose (Millipore) and eluted with 2 × Laemmli buffer.
DRG purification for mass spectrometry analyses. For exogenous DRG analyses, HEK293T cells were transfected with the pCDNA3 HA-DRG1/V5-DFRP1 or pCDNA3 HA-DRG2/V5-DFRP2 vectors in the presence or absence of pCDNA3 FLAG-JMJD7. Cells were incubated under standard culture conditions for 48 h before lysis in JIES buffer and immunoaffinity purification of DRG-DFRP complexes using anti-HA agarose beads (Sigma, A2095) at 4 °C for 16 h with rotation. Beads were washed five times with JIES before elution with anti-HA peptide (Sigma, I2149), protease digest and MS analysis. For endogenous DRG analyses, large-scale cell cultures were lysed in JIES buffer before immunoaffinity purification using the antibodies described above. Beads were washed with JIES buffer and eluted with 2 × Laemmli buffer and separated by SDS-PAGE. DRG1 and DRG2 protein bands were excised from Coomassie-stained gels before protease digest and mass spectrometry analysis.
RNA interaction assays. HEK293T cells were transfected with pCDNA3 FLAG-DRG1, -DRG1-K22A, -DRG2 or -DRG2-K21A. Alternatively, stable HEK293T cell lines expressing conditional control and JMJD7 shRNA were treated with 1 μ g ml −1 doxycycline for 72 h before transfection with pCDNA3 FLAG-DRG2. Forty-eight hours after transfections, cells were lysed in JIES buffer, and then centrifuged (22,000g, 10 min) to remove cell debris. Protein extracts were used directly in RNA pulldown assays, or were subject to anti-FLAG immunoprecipitation and elution (as above) to purify FLAG-DRG proteins for use in RNA pulldown assays (in the presence of JIES buffer supplemented with 1 mM dithiothreitol). Samples were incubated with either 4 mg polycytidylic acid-agarose beads (Sigma, P9827), 4 mg polyuridylic acid-agarose beads (Sigma, P8563) or 20 μ l control protein A agarose beads (Millipore, 16-156) at 4 °C for 2 h with rotation. Beads were washed five times with JIES before elution with 30 μ l 2 × Laemmli buffer.
Cellular protein mass spectrometry. Protein samples were digested and desalted using standard methods for in-gel 50 and in-solution 49 digest. Desalted samples were analyzed by nLC-MS/MS with front-end separation using a Dionex Ultimate 3000 UPLC at a flow rate of 250 nl min −1 . Peptides were separated using a PepMAP C18 column (75 μ m × 500 mm, 2 μ m particle size) and a 1 h gradient of 2-35% acetonitrile in 5% dimethylsulfoxide/0.1% formic acid. For MS detection, we used a Q-Exactive, Q-Exactive HF or Orbitrap Fusion Lumos (all Thermo) in higherenergy collision-induced dissociation (HCD) mode (Q-Exactives) or CID/Ion trap detection mode for MS/MS data acquisition with the parameters specified in Supplementary Table 3 . Data were searched against the UniProt Reference Homo sapiens database (retrieved December 15, 2014) with PEAKS Studio 7.5 (Bioinformatics Solutions) with 10 ppm mass error tolerance for precursor mass and 0.05 Da (Q-Exactives)/0.5 Da (Orbitrap Fusion Lumos) tolerance for fragment masses. Carbamidomethylation on cysteine was selected as a 'fixed' modification, while oxidation (M), deamidation (N, Q) and hydroxylation (P, K, D, N, R, Y) were selected as variable modifications for the database search. Using a target/decoy fusion approach, the peptide false discovery rate was set to 1%. Peptide abundance was measured as accumulated ion counts after extraction of the chromatographic elution profile of the precursor mass of interest using Qual Browser, Xcalibur 3.0.63 (Thermo).
In vitro JMJD7-DRG interaction assay. HA-DRG1, -DRG1-K22A, -DRG2 and -DRG2-K21A proteins were produced in vitro using the TNT Quick-Coupled transcription/translation system (Promega, L1170). IVVT reactions and anti-FLAG M2 Magnetic Beads (Sigma, m8823) were spiked into HEK293T cell lysates expressing either pCDNA3 or pCDNA3-FLAG-JMJD7 before overnight incubation at 4 °C for 16 h with rotation. Anti-FLAG beads were washed three times with JIES buffer before eluting with 50 μ l 2 × Laemmli buffer. Fig. 3a .
Protein Basic Local Alignment
Recombinant protein production and purification. All recombinant JMJD7 proteins were produced with N-terminal His 6 tags in E. coli Rosetta (DE3) pLysS cells (Novagen). Cells were grown in 2TY media at 37 °C to an OD 600 nm of 0.6-0.8. Recombinant protein production was induced with 0.5 mM isopropyl β -d-1-thiogalactopyrandoside; cells were then grown overnight at 18 °C. Proteins were purified by nickel affinity chromatography using an AKTA FPLC system (GE Healthcare). Recombinant protein was eluted from the column using a stepwise gradient (30-250 mM imidazole), and protein-containing fractions were further purified by size-exclusion chromatography using a Superdex 75 10/300 GL column (Amersham Pharmacia Biosciences). Protein purity was assessed by SDS-PAGE analysis, and fractions with > 90-95% purity were subsequently pooled, concentrated (10-25 mg ml −1 ), flash-frozen in liquid nitrogen and then stored at − 80 °C in 50 mM HEPES, 200 mM NaCl, 2% glycerol, pH 7.5.
Recombinant DRG1 was produced and purified as reported previously 51 . The TEV protease was used for His 6 -tag cleavage (1:20, TEV/DRG1) with overnight treatment at 4 °C. DRG1 was collected as the eluent after a 5 ml HiTrap nickel column treatment. DRG1 purity was validated by SDS-PAGE and MS analyses.
Recombinant DRG1 hydroxylation.
Purified, full-length DRG1 was hydroxylated by treatment with His 6 -JMJD7. Assay mixtures contained 50 μ M DRG1, 2 μ M JMJD7, 100 μ M ammonium iron(ii) sulfate hexahydrate (Fe(ii)), 500 μ M 2-oxoglutarate acid disodium salt, 1 mM (+ )-sodium l-ascorbate (ascorbate) in 50 mM HEPES, 500 mM NaCl, 5% glycerol, pH 7.5. The reaction was carried out for 2 h at 37 °C. Hydroxylated DRG1 was collected as the eluent after a 5 ml HiTrap nickel column treatment. Hydroxylation was confirmed by MS analysis using a Xevo GS-2-S mass spectrometer (Waters). Greater than 95% hydroxylation, as observed by MS, was achieved under the stated conditions. The concentration of the hydroxylated samples was determined using a ND-1000 Spectrophotometer (Nanodrop Technologies).
Peptide synthesis. The 25-mer DRG1 (ARTQKNKATAHHLGLLKARLAKLRR-NH 2 , > 95%) and DRG2 (ARTQKNKATEYHLGLLKAKLAKYRA-NH 2 , > 95%) peptides were commercially synthesized with C-terminal amides by either Severn Biotech (UK) or GL BioChem (China).
The DRG1 [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] peptide (NKATAHHLGLLKARLAKLRR-NH 2 ) was synthesized in-house by solid-phase synthesis using a Liberty Blue automated microwave peptide synthesizer (CEM Corporation) for amino-acid analysis as described previously 32 . All other peptides used for screening were synthesized using a Multipep RSi solid-phase peptide synthesizer (Intavis AG Bioanalytical Instruments) on a plate module (1-5 mg scale) using Tentagel S-RAM resin as described previously 32 . All peptides were synthesized as C-terminal amides. The DRG1 [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] peptide used for amino-acid analysis was purified by reverse-phase high-performance liquid chromatography using a Vydac C18 column (Solvent A = 0.1% trifluoroacetic acid in water; Solvent B = 0.1% trifluoroacetic acid in acetonitrile) to > 90% purity as determined by LC-MS. Peptides used for screening assays were not purified. JMJD7 activity assays. JMJD7 NMR activity assays. NMR assays were carried out as described previously 32 . Reactions (160 µ l) were prepared in a 1.5 ml Eppendorf tube with 16 µ l D 2 O (Sigma-Aldrich), ± 100 µ M Fe(ii), 200 µ M 2OG, ± 500 µ M ascorbate, ± 1 mM NOG, ± 10 µ M JMJD7 and ± 10 µ M JMJD7-H178A in 20 mM Tris-D 11 (Cambridge Isotope Laboratories), pH 7.5. Reactions were initiated by the addition of JMJD7 or JMJD7-H178A and immediately transferred to a 3 mm Shigemi NMR tube, which was centrifuged for a few seconds in a hand centrifuge.
Proton NMR spectra were acquired, and the reaction was monitored in real time on a Bruker Avance III 700 MHz spectrometer equipped with a 5 mm inverse TCI cryoprobe at 298 K and controlled by TopSpin 3.5. The AV700 was controlled by TopSpin software, and spectrometer conditions were optimized using a control sample with all reaction components except JMJD7 before data acquisition. The first proton spectrum was acquired with water suppression (16 scans), 325 s after mixing, following brief optimization (start of data acquisition was 225 s). Spectra were automatically acquired every 105 s for 1,900 s. TopSpin 3.2 software was used to process and integrate the peaks corresponding to 2OG and succinate for analysis using Microsoft Excel 2003.
Matrix-assisted laser desorption/ionization mass spectrometry hydroxylation assays. JMJD7 assay mixtures (final volume 20 µ l in 50 mM HEPES, pH 7.5) containing 50 µ M peptide and 10 µ M His 6 -JMJD7 were incubated for 60 min at 37 °C with 100 µ M Fe(ii), 200 µ M 2OG and 500 µ M ascorbate. Reactions were quenched by immediately spotting 1 µ l of assay sample and 1 µ l of α -cyano-4-hydroxycinnamic acid (CHCA) matrix solution (saturated CHCA in 50% acetonitrile, 50% water, 0.1% trifluoroacetic acid) onto a Waters 96-spot MALDI plate. The samples were analyzed using MALDI-MS and a Waters Micromass MALDI micro MX instrument in the positive-ion reflectron mode. MALDI-MS spectra were analyzed using MassLynx 4.1 (Waters) by baseline subtraction (polynomial order, 15; below curve %, 10; tolerance, 0.01) and smoothing (number of smooths, 2; smooth window channels, 10; Savitzky-Golay).
Co-factor/substrate dependence assays. Co-factor/substrate dependence assays (Fig. 3d ) were performed as described above with the following modifications: 50 µ M DRG1 , ± 1 µ M JMJD7 or JMJD7-H178A, ± 100 µ M Fe(ii), ± 500 µ M 2OG, ± 1 mM ascorbate, ± 1 mM NOG, and quenching after 5 min of incubation at 37 °C with formic acid (2% final concentration) before spotting on the MALDI plate. 18 O 2 incorporation assays. Hydroxylation of DRG1 by JMJD7 was performed under an atmosphere of argon, 16 O 2 or 18 O 2 (CK Isotopes, 98%) as described previously 12 . Assays were performed under the following conditions: 50 µ M DRG1 , ± 2.5 µ M JMJD7, 100 µ M Fe(ii), 500 µ M 2OG and 1 mM ascorbate in 50 mM HEPES, pH 7.5. A solution of peptide and buffer (94 µ l) in a septumsealed glass vial was purged with N 2 for 30 min on ice using a mass flow controller (Brooks Instruments) and an escape needle. One microliter each of 2OG, Fe(ii), ascorbate and JMJD7 were then sequentially added on ice using gas-tight Hamiltonian syringes. A balloon attached to a syringe was purged three times with argon and then filled with the gas of choice (argon, 16 O 2 and 18 O 2 ). The reaction was initiated by slowly bubbling the gas into the solution at room temperature using an escape needle until the balloon was deflated (~10 min). The escape needle was removed, followed by the balloon; the solution was then incubated at 37 °C for an additional 20 min and quenched with 100 µ l of 4% formic acid. Products were analyzed by MALDI-MS as above.
Non-denaturing mass spectrometry. Stoichiometry measurements were performed using a hybrid quadrupole-Orbitrap (Thermo Q-Exactive) and a quadrupole-time-of-flight (Waters Synapt G2Si) instrument for detection of high-mass ions 52, 53 . Samples (10 µ M) were buffer-exchanged into 200 mM ammonium acetate using Bio-spin 6 (Bio-Rad) centrifuge columns immediately before analysis. Ions were generated by static nanoelectrospray using gold-coated capillaries prepared in-house. Data were obtained with a wide acquisition window (2,000-10,000 m/z); desolvation was achieved with moderate HCD voltage (Q-Exactive; 10-50 V) or CID (Synapt; 4 V) applied. Instrument settings were (Q-Exactive): capillary voltage = 1.1 kV; source temperature = 50 °C; maximum injection time = 50 ms; S-lens RF = 100; C-trap entrance lens = 5.8. Spectra were obtained with 10 microscans, averaged over 100 scans. Instrument settings were as follows (Synapt): capillary voltage = 1.4 kV; source temperature = 50 °C; sample cone = 10 V; trap d.c. bias = 10 V. Data were processed using XCalibur 2.1 (Thermo Scientific) and MassLynx V4.1 (Waters) software and masses were assigned using in-house software (Mass/Charge State Error Determination v 0.3; http://benesch.chem.ox.ac.uk/resources.html).
Size-exclusion chromatography/multiangle light scattering and circular dichroism studies. Analysis of JMJD7 was performed using an Agilent 1260 HPLC with a Superdex 200 Increase 3.2/300 SEC column (GE Healthcare) coupled to a DAWN HELEOS II scattering detector (Wyatt Technologies) and Optilab T-rEX (Wyatt Technologies) differential refractive index detector. The MALS detector was equilibrated overnight in running buffer to ensure minimal background light scattering. About 30 μ g of protein was loaded on-column (column compartment was set to 20 °C) at a flow rate of 75 µ l min −1 in 50 mM HEPES, 200 mM NaCl, 2% glycerol, pH 7.5. Data acquisition and analysis were performed with Astra 6.1 software (Wyatt Technologies).
CD spectra were acquired using a Chirascan CD spectrometer (Applied Photophysics model) equipped with a Peltier temperature-control cell holder. Experiments were performed at 20 °C in a 0.1 cm path-length cuvette using 0.2 mg ml −1 of protein in 10 mM sodium phosphate buffer, pH 8.0. Data were
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